Physician profile
Michelle B Surrett
NPI 1114110665
$1,511.44
in general payments reported to CMS, 2019-2025
28 companies · $796 in 2025
The $796 reported for 2025 was more than what 87% of Occupational Health (Nurse Practitioner) providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $716 · 2025: $796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.76 | 2024-2025 | |
| Corcept Therapeutics | $167.97 | 2024-2025 | Korlym |
| Astrazeneca Pharmaceuticals Lp | $109.50 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Dynavax Technologies Corporation | $88.96 | 2024-2025 | Heplisav-B |
| Otsuka America Pharmaceutical, INC. | $78.55 | 2024-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.88 | 2024-2025 | Xifaxan, Trulance |
| Pfizer INC. | $60.22 | 2024-2025 | |
| Novo Nordisk INC | $50.84 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $49.95 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $44.25 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $43.36 | 2024 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $39.97 | 2024 | |
| Stryker Corporation | $38.75 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $34.05 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Sumitomo Pharma America, INC. | $32.72 | 2025 | Gemtesa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $32.37 | 2024 | Exablate |
| Sanofi-Aventis U.S. LLC | $30.15 | 2025 | |
| Edwards Lifesciences Corporation | $28.78 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Organon LLC | $25.78 | 2024 | |
| Daiichi Sankyo INC. | $23.67 | 2024 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $20.71 | 2024 | Trintellix |
| Phathom Pharmaceuticals, INC. | $20.09 | 2024 | Voquezna |
| Abbott Laboratories | $20.06 | 2025 | Freestyle Libre 3 |
| Alexion Pharmaceuticals, INC. | $18.75 | 2024 | Strensiq |
| Vanda Pharmaceuticals INC. | $18.55 | 2025 | Hetlioz, Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.49 | 2024 | Caplyta |
| Amgen INC. | $14.27 | 2025 | Otezla, Repatha |
| Cvrx, INC. | $12.04 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Surrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.